The Safety Net FoundationThrough The Safety Net Foundation, Amgen supports qualifying people who might go without important medicines because of financial barriers. The Safety Net Foundation is a nonprofit foundation supported by Amgen that provides Amgen products at no cost to qualifying people with no or limited drug coverage. The Safety Net Foundation covers Aranesp® (darbepoetin alfa), EPOGEN® (Epoetin alfa), Neulasta® (pegfilgrastim), NEUPOGEN® (Filgrastim), Nplate® (romiplostim), Prolia® (denosumab), Sensipar® (cinacalcet), Vectibix® (panitumumab), and XGEVA® (denosumab) To qualify, a person must:
|
Medication
Prescribing Information |